🚀 VC round data is live in beta, check it out!
Surgery Partners Valuation Multiples
Discover revenue and EBITDA valuation multiples for Surgery Partners and similar public comparables like Astrana Health, Draegerwerk, OdontoPrev, Mitra Keluarga and more.
Surgery Partners Overview
About Surgery Partners
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
Founded
2015
HQ
Employees
15.0K
Website
Sectors
Financials (LTM)
EV
$6B
Surgery Partners Financials
Surgery Partners reported last 12-month revenue of $3B and EBITDA of $528M.
In the same LTM period, Surgery Partners generated $1B in gross profit, $528M in EBITDA, and $55M in net income.
Revenue (LTM)
Surgery Partners P&L
In the most recent fiscal year, Surgery Partners reported revenue of $3B and EBITDA of $566M.
Surgery Partners expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $1B | XXX | $765M | XXX | XXX | XXX |
| Gross Margin | 38% | XXX | 23% | XXX | XXX | XXX |
| EBITDA | $528M | XXX | $566M | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $55M | XXX | $60M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | — | — | $3B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Surgery Partners Stock Performance
Surgery Partners has current market cap of $2B, and enterprise value of $6B.
Market Cap Evolution
Surgery Partners' stock price is $14.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $2B | 4.2% | XXX | XXX | XXX | $0.46 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSurgery Partners Valuation Multiples
Surgery Partners trades at 1.7x EV/Revenue multiple, and 10.6x EV/EBITDA.
EV / Revenue (LTM)
Surgery Partners Financial Valuation Multiples
As of April 18, 2026, Surgery Partners has market cap of $2B and EV of $6B.
Equity research analysts estimate Surgery Partners' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Surgery Partners has a P/E ratio of 32.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 10.6x | XXX | 9.9x | XXX | XXX | XXX |
| EV/EBIT | 15.7x | XXX | 11.9x | XXX | XXX | XXX |
| EV/Gross Profit | 4.5x | XXX | 7.3x | XXX | XXX | XXX |
| P/E | 32.7x | XXX | 30.4x | XXX | XXX | XXX |
| EV/FCF | 37.7x | XXX | 28.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Surgery Partners Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Surgery Partners Margins & Growth Rates
Surgery Partners' revenue in the last 12 month grew by 4%.
Surgery Partners' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Surgery Partners' rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Surgery Partners' rule of X is 23% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Surgery Partners Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | (6%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 23% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 9% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Surgery Partners Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Surgery Partners | XXX | XXX | XXX | XXX | XXX | XXX |
| Astrana Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Draegerwerk | XXX | XXX | XXX | XXX | XXX | XXX |
| OdontoPrev | XXX | XXX | XXX | XXX | XXX | XXX |
| Mitra Keluarga | XXX | XXX | XXX | XXX | XXX | XXX |
| Pediatrix | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Surgery Partners M&A Activity
Surgery Partners acquired XXX companies to date.
Last acquisition by Surgery Partners was on XXXXXXXX, XXXXX. Surgery Partners acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Surgery Partners
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSurgery Partners Investment Activity
Surgery Partners invested in XXX companies to date.
Surgery Partners made its latest investment on XXXXXXXX, XXXXX. Surgery Partners invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Surgery Partners
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Surgery Partners
| When was Surgery Partners founded? | Surgery Partners was founded in 2015. |
| Where is Surgery Partners headquartered? | Surgery Partners is headquartered in United States. |
| How many employees does Surgery Partners have? | As of today, Surgery Partners has over 15K employees. |
| Who is the CEO of Surgery Partners? | Surgery Partners' CEO is J. Eric Evans. |
| Is Surgery Partners publicly listed? | Yes, Surgery Partners is a public company listed on Nasdaq. |
| What is the stock symbol of Surgery Partners? | Surgery Partners trades under SGRY ticker. |
| When did Surgery Partners go public? | Surgery Partners went public in 2015. |
| Who are competitors of Surgery Partners? | Surgery Partners main competitors are Astrana Health, Draegerwerk, OdontoPrev, Mitra Keluarga. |
| What is the current market cap of Surgery Partners? | Surgery Partners' current market cap is $2B. |
| What is the current revenue of Surgery Partners? | Surgery Partners' last 12 months revenue is $3B. |
| What is the current revenue growth of Surgery Partners? | Surgery Partners revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Surgery Partners? | Current revenue multiple of Surgery Partners is 1.7x. |
| Is Surgery Partners profitable? | Yes, Surgery Partners is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Surgery Partners? | Surgery Partners' last 12 months EBITDA is $528M. |
| What is Surgery Partners' EBITDA margin? | Surgery Partners' last 12 months EBITDA margin is 16%. |
| What is the current EV/EBITDA multiple of Surgery Partners? | Current EBITDA multiple of Surgery Partners is 10.6x. |
| What is the current FCF of Surgery Partners? | Surgery Partners' last 12 months FCF is $148M. |
| What is Surgery Partners' FCF margin? | Surgery Partners' last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Surgery Partners? | Current FCF multiple of Surgery Partners is 37.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.